ItalyOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Obstetrics & Reproductive Medicine
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,909 out of 101,272 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 327,843 | 286,963 |
| Total Cites | 395 | 504 |
| H-index | 8 | 10 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 45 | 54 |
| Number of Single+First+Last Authored Papers | 92 | 92 |
| Total Cites to Single+First+Last Authored Papers | 149 | 182 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 350 | 393 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.28 |
| Self-Citation Percentage |
21.63%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Obstetrics & Reproductive Medicine
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,641 out of 96,407 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 260,203 | 164,592 |
| Total Cites | 371 | 480 |
| H-index | 8 | 10 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 2 | 4 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 40 | 60 |
| Number of Single+First+Last Authored Papers | 83 | 83 |
| Total Cites to Single+First+Last Authored Papers | 182 | 227 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 315 | 345 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.39 |
| Self-Citation Percentage |
22.71%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Obstetrics & Reproductive Medicine
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,677 out of 87,536 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 244,375 | 104,709 |
| Total Cites | 234 | 402 |
| H-index | 6 | 8 |
| Hm-index | 3 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 11 | 19 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 44 | 90 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 96 | 189 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 207 | 234 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.72 |
| Self-Citation Percentage |
41.79%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Obstetrics & Reproductive Medicine
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,511 out of 85,185 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 216,268 | 130,785 |
| Total Cites | 333 | 480 |
| H-index | 9 | 11 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 13 | 20 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 73 | 109 |
| Number of Single+First+Last Authored Papers | 57 | 57 |
| Total Cites to Single+First+Last Authored Papers | 152 | 223 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 297 | 341 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.41 |
| Self-Citation Percentage |
30.63%
|
|
Related Profiles
Top 2% Scientists by Country
236,132 scientists from 167 countries on the 2025 single-year list.
Italy7,991 scientists, 7th in the world
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.